MLYS
Price
$16.66
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
1.06B
80 days until earnings call
PTGX
Price
$45.82
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
2.85B
69 days until earnings call
Interact to see
Advertisement

MLYS vs PTGX

Header iconMLYS vs PTGX Comparison
Open Charts MLYS vs PTGXBanner chart's image
Mineralys Therapeutics
Price$16.66
Change-$0.00 (-0.00%)
Volume$9.47K
Capitalization1.06B
Protagonist Therapeutics
Price$45.82
Change-$0.00 (-0.00%)
Volume$9.56K
Capitalization2.85B
MLYS vs PTGX Comparison Chart
Loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLYS vs. PTGX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a StrongBuy and PTGX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (MLYS: $16.66 vs. PTGX: $45.82)
Brand notoriety: MLYS and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 1% vs. PTGX: 1%
Market capitalization -- MLYS: $1.06B vs. PTGX: $2.85B
MLYS [@Biotechnology] is valued at $1.06B. PTGX’s [@Biotechnology] market capitalization is $2.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 0 FA rating(s) are green whilePTGX’s FA Score has 2 green FA rating(s).

  • MLYS’s FA Score: 0 green, 5 red.
  • PTGX’s FA Score: 2 green, 3 red.
According to our system of comparison, PTGX is a better buy in the long-term than MLYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 5 TA indicator(s) are bullish while PTGX’s TA Score has 4 bullish TA indicator(s).

  • MLYS’s TA Score: 5 bullish, 4 bearish.
  • PTGX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MLYS is a better buy in the short-term than PTGX.

Price Growth

MLYS (@Biotechnology) experienced а +8.46% price change this week, while PTGX (@Biotechnology) price change was +3.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.79%. For the same industry, the average monthly price growth was +2.85%, and the average quarterly price growth was -2.67%.

Reported Earning Dates

MLYS is expected to report earnings on Aug 11, 2025.

PTGX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+0.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($2.85B) has a higher market cap than MLYS($1.06B). MLYS YTD gains are higher at: 35.337 vs. PTGX (18.705). PTGX has higher annual earnings (EBITDA): 30.1M vs. MLYS (-192.36M). PTGX has more cash in the bank: 574M vs. MLYS (198M). PTGX has higher revenues than MLYS: PTGX (208M) vs MLYS (0).
MLYSPTGXMLYS / PTGX
Capitalization1.06B2.85B37%
EBITDA-192.36M30.1M-639%
Gain YTD35.33718.705189%
P/E RatioN/A58.86-
Revenue0208M-
Total Cash198M574M34%
Total DebtN/A11.4M-
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
42
SMR RATING
1..100
26
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLYSPTGX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 10 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 3 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEEHX27.02N/A
N/A
Steward Values Enhanced Lg Cap R6
BTECX13.34N/A
N/A
Baron Technology Institutional
VGIAX101.73N/A
N/A
Vanguard Growth & Income Adm
CRRYX13.96N/A
N/A
Columbia Small Cap Value II Inst3
BGIFX14.99-0.01
-0.03%
Baillie Gifford International Alpha 3

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PTGX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
N/A
PTGX - MLYS
49%
Loosely correlated
N/A
CKPT - MLYS
41%
Loosely correlated
N/A
XERS - MLYS
38%
Loosely correlated
N/A
ACLX - MLYS
35%
Loosely correlated
-0.50%
APGE - MLYS
35%
Loosely correlated
+0.45%
More

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been loosely correlated with MLYS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PTGX jumps, then MLYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
N/A
MLYS - PTGX
48%
Loosely correlated
N/A
CKPT - PTGX
47%
Loosely correlated
N/A
TRVI - PTGX
42%
Loosely correlated
N/A
DNLI - PTGX
41%
Loosely correlated
-0.22%
ORMP - PTGX
37%
Loosely correlated
N/A
More